| Commercial | Medicare | ||
---|---|---|---|---|
No Pegfilgrastim Use | Pegfilgrastim Use | No Pegfilgrastim Use | Pegfilgrastim Use | |
(n = 16,512) | (n = 34,266) | (n = 20,195) | (n = 50,842) | |
Patient | ||||
 Age (years) | ||||
  Mean (SD) | 54.3 (10.2) | 56.2 (10.9) | 72.3 (5.4) | 73.6 (5.9) |
 Female, N (%) | 14,623 (89%) | 29,995 (88%) | 16,604 (82%) | 37,811 (74%) |
 Chronic Comorbidities, N (%) | ||||
  Cardiovascular Disease | 1403 (8%) | 3851 (11%) | 6124 (30%) | 16,979 (33%) |
  Diabetes | 1750 (11%) | 4211 (12%) | 5217 (26%) | 13,022 (26%) |
  Liver Disease | 621 (4%) | 1386 (4%) | 731 (4%) | 1999 (4%) |
  Lung Disease | 1290 (8%) | 3157 (9%) | 3033 (15%) | 8053 (16%) |
  Renal Disease | 311 (2%) | 855 (2%) | 1523 (8%) | 4598 (9%) |
  Osteoarthritis | 1382 (8%) | 3361 (10%) | 4534 (22%) | 11,620 (23%) |
  Rheumatoid Disease | 236 (1%) | 561 (2%) | 670 (3%) | 1798 (4%) |
  Thyroid Disorder | 2105 (13%) | 4569 (13%) | 4470 (22%) | 11,723 (23%) |
 Body Weight and Nutritional Status, N (%) | ||||
  Obese | 1244 (8%) | 2688 (8%) | 1715 (8%) | 3959 (8%) |
  Malnutrition | 71 (0%) | 289 (1%) | 414 (2%) | 1517 (3%) |
 Proxies for Health Status, N (%) | ||||
  Hospice Care | 38 (0%) | 120 (0%) | 572 (3%) | 2037 (4%) |
  SNF | 100 (1%) | 244 (1%) | 926 (5%) | 2194 (4%) |
  Hospice or SNF | 136 (1%) | 352 (1%) | 1400 (7%) | 3962 (8%) |
 Proxies for Physical Function, N (%) | ||||
  Use of Hospital Bed | 26 (0%) | 78 (0%) | 162 (1%) | 476 (1%) |
  Use of Supplemental Oxygen | 259 (2%) | 681 (2%) | 810 (4%) | 2285 (4%) |
  Use of Walking Aid | 192 (1%) | 506 (1%) | 772 (4%) | 2455 (5%) |
  Use of Wheel Chair | 53 (0%) | 136 (0%) | 378 (2%) | 997 (2%) |
  Any of Above | 487 (3%) | 1256 (4%) | 1807 (9%) | 5268 (10%) |
 Use of Immunosuppressive Drugs, N (%) | 5273 (32%) | 11,113 (32%) | 6612 (33%) | 17,145 (34%) |
 Other Conditions/Events Prior to Chemotherapy, N (%) | ||||
  Anemia | 1896 (11%) | 4721 (14%) | 6025 (30%) | 17,970 (35%) |
  Neutropenia | 290 (2%) | 1295 (4%) | 948 (5%) | 4738 (9%) |
  Infection | 7902 (48%) | 17,204 (50%) | 11,545 (57%) | 29,868 (59%) |
  Recent Surgery (prior 90 days) | 13,881 (84%) | 28,100 (82%) | 13,024 (64%) | 30,427 (60%) |
  History of Hospitalization for Any Reason | 4549 (28%) | 9985 (29%) | 7739 (38%) | 20,374 (40%) |
  History of Chemotherapy | 866 (5%) | 2127 (6%) | 1623 (8%) | 4755 (9%) |
  History of Radiation Therapy | 910 (6%) | 1955 (6%) | 883 (4%) | 2140 (4%) |
Cancer and Chemotherapy, N (%) | ||||
 Breast Cancer | 13,261 (80%) | 26,622 (78%) | 13,305 (66%) | 25,675 (50%) |
  TAC | 389 (2%) | 4179 (12%) | 235 (1%) | 1857 (4%) |
  TC | 8793 (53%) | 14,918 (44%) | 8032 (40%) | 19,493 (38%) |
  TCH | 4079 (25%) | 7525 (22%) | 5038 (25%) | 4325 (9%) |
 NHL — CHOP±R | 3251 (20%) | 7644 (22%) | 6890 (34%) | 25,167 (50%) |
 Year of Chemotherapy (Commercial), N (%) | ||||
  2010–2011 | 7150 (43%) | 13,308 (39%) | – | – |
  2012–2013 | 6108 (37%) | 13,108 (38%) | – | – |
  2014–2015 | 3254 (20%) | 7850 (23%) | – | – |
 Year of Chemotherapy (Medicare), N (%) | ||||
  2007–2009 | – | – | 6268 (31%) | 12,984 (26%) |
  2010–2012 | – | – | 8615 (43%) | 21,004 (41%) |
  2013–2015 | – | – | 5312 (26%) | 16,854 (33%) |